Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis

Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis

Bone mineral density (BMD) reduction and fragility fractures still represent a major source of morbidity in rheumatoid arthritis (RA) patients, despite adequate control of the disease. An increasing number of clinical and experimental evidence supports the role of autoantibodies, especially anti-cit...

Full description

Bibliographic Details
Main Authors: Bernardo D’Onofrio, Michele di Lernia, Ludovico De Stefano, Serena Bugatti, Carlomaurizio Montecucco, Laura Bogliolo
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
osteoporosis
anti-citrullinated antibodies
rheumatoid arthritis
denosumab
Online Access:https://www.mdpi.com/2077-0383/11/9/2341

Internet

https://www.mdpi.com/2077-0383/11/9/2341

Similar Items